RS
Renuka Saurabh Borole
About Renuka Saurabh Borole
Data last updated:
Renuka Saurabh Borole is a Director at Goldline Pharmaceutical Limited (since 2024), Director at Goldline Pharmaceutical Limited (since 2024) and Director at Dra Consultants Limited (since 2024), and holds 1 more current directorship. The companies operate in Pharma, Business Outsourcing and Environment. The 4 current companies with reported revenue have a combined latest revenue of ₹78.44 Cr; the largest is Goldline Pharmaceutical Limited at ₹28.06 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Sep 2024 | 2004 | ₹28.06 Cr (FY 2025) | Active | |
| Director | 30 Sep 2024 | 2004 | ₹28.06 Cr (FY 2025) | Active | |
| Director | 14 Aug 2024 | 2009 | ₹22.30 Cr (FY 2025) | Active | |
| Director | 12 May 2025 | 2011 | ₹2.7 Lakh (FY 2025) | Active |
Board colleagues of Renuka Saurabh Borole
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Renuka Saurabh Borole
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Renuka Saurabh Borole
Renuka Saurabh Borole currently holds 4 directorships: Goldline Pharmaceutical Limited (Director, since 30 Sep 2024, revenue ₹28.06 Cr (FY 2025)); Goldline Pharmaceutical Limited (Director, since 30 Sep 2024, revenue ₹28.06 Cr (FY 2025)); Dra Consultants Limited (Director, since 14 Aug 2024, revenue ₹22.30 Cr (FY 2025)); Jiya Eco-Products Limited (Director, since 12 May 2025, revenue ₹2.7 Lakh (FY 2025)).
Renuka Saurabh Borole was first appointed on 14 Aug 2024 as Director at Dra Consultants Limited. The most recent appointment on record is 12 May 2025 at Jiya Eco-Products Limited.
The 4 current companies of Renuka Saurabh Borole that report revenue have a combined latest revenue of ₹78.44 Cr: Goldline Pharmaceutical Limited ₹28.06 Cr (FY 2025); Goldline Pharmaceutical Limited ₹28.06 Cr (FY 2025); Dra Consultants Limited ₹22.30 Cr (FY 2025); Jiya Eco-Products Limited ₹2.7 Lakh (FY 2025).
The current boards of Renuka Saurabh Borole's companies include Amol Laxmikant Mujumdar (Goldline Pharmaceutical Limited), Avinash Pandurang Ambulkar (Goldline Pharmaceutical Limited), Dipti Sharad Bhusari (Goldline Pharmaceutical Limited), Mehul Hari Ranade (Goldline Pharmaceutical Limited), Prashant Shrikrishna Karkare (Goldline Pharmaceutical Limited), Prashant Vithalrao Rahate (Goldline Pharmaceutical Limited), among others.